Long-term Outcomes Following Multimodal Therapy in Patients with Metastatic Uveal Melanoma: A Case Study - Summary - MDSpire

Long-term Outcomes Following Multimodal Therapy in Patients with Metastatic Uveal Melanoma: A Case Study

  • By

  • Francesca Rifaldi

  • Martina Angi

  • Giuseppe Leone

  • Marta De Ponti

  • Marta Vaiani

  • Andrea Spagnoletti

  • Alice Indini

  • Michele Del Vecchio

  • Lorenza Alessia Di Guardo

  • April 24, 2026

  • 0 min

Share

Objective:

To evaluate the long-term outcomes of a patient with metastatic uveal melanoma treated with tebentafusp and stereotactic body radiotherapy.

Key Findings:
  • Add context to the findings to explain their significance in the broader scope of treatment for metastatic uveal melanoma.
Interpretation:

Expand on the implications of the findings for future research directions.

Limitations:
  • Include a point about the need for diverse patient demographics in future studies.
Conclusion:

Emphasize the potential impact of the findings on clinical practice.

Original Source(s)

Long-term Outcomes Following Multimodal Therapy in Patients with Metastatic Uveal Melanoma: A Case Study

  • by Francesca Rifaldi, Martina Angi, Giuseppe Leone, Marta De Ponti, Marta Vaiani, Andrea Spagnoletti, Alice Indini, Michele Del Vecchio, Lorenza Alessia Di Guardo

  • April 24, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma